CN108586519A - 一种有机硅烷或有机锗烷衍生物的制备方法 - Google Patents
一种有机硅烷或有机锗烷衍生物的制备方法 Download PDFInfo
- Publication number
- CN108586519A CN108586519A CN201810417009.0A CN201810417009A CN108586519A CN 108586519 A CN108586519 A CN 108586519A CN 201810417009 A CN201810417009 A CN 201810417009A CN 108586519 A CN108586519 A CN 108586519A
- Authority
- CN
- China
- Prior art keywords
- palladium
- preparation
- hexamethyl
- organic
- germanium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 germanium alkane Chemical class 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 29
- 229910052732 germanium Inorganic materials 0.000 title claims abstract description 25
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims abstract description 77
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 49
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 40
- 229910052763 palladium Inorganic materials 0.000 claims abstract description 38
- 238000006243 chemical reaction Methods 0.000 claims abstract description 34
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 24
- 239000012074 organic phase Substances 0.000 claims abstract description 23
- 238000004440 column chromatography Methods 0.000 claims abstract description 20
- 229910052710 silicon Inorganic materials 0.000 claims abstract description 16
- 239000010703 silicon Substances 0.000 claims abstract description 16
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000003513 alkali Substances 0.000 claims abstract description 11
- 239000003054 catalyst Substances 0.000 claims abstract description 11
- 239000003446 ligand Substances 0.000 claims abstract description 11
- 239000004215 Carbon black (E152) Substances 0.000 claims abstract description 10
- 229930195733 hydrocarbon Natural products 0.000 claims abstract description 10
- 239000003960 organic solvent Substances 0.000 claims abstract description 10
- 150000001336 alkenes Chemical class 0.000 claims abstract description 8
- 238000005406 washing Methods 0.000 claims abstract description 6
- 238000001914 filtration Methods 0.000 claims abstract description 5
- 239000000463 material Substances 0.000 claims abstract description 5
- 238000001035 drying Methods 0.000 claims abstract description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 60
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims description 42
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims description 21
- 229910000024 caesium carbonate Inorganic materials 0.000 claims description 21
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims description 10
- 229910052736 halogen Inorganic materials 0.000 claims description 10
- 150000002367 halogens Chemical class 0.000 claims description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 claims description 8
- 150000003003 phosphines Chemical class 0.000 claims description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical class OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 6
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 claims description 6
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 claims description 5
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims description 5
- 235000010290 biphenyl Nutrition 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 claims description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical class ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 3
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims description 3
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 claims description 3
- JHDCDEHVUADNKQ-UHFFFAOYSA-N 3-(trifluoromethyl)-1h-pyridin-2-one Chemical class OC1=NC=CC=C1C(F)(F)F JHDCDEHVUADNKQ-UHFFFAOYSA-N 0.000 claims description 3
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical group N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 claims description 3
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims description 3
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical group [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 claims description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 3
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 3
- 125000002252 acyl group Chemical group 0.000 claims description 3
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- TWKVUTXHANJYGH-UHFFFAOYSA-L allyl palladium chloride Chemical class Cl[Pd]CC=C.Cl[Pd]CC=C TWKVUTXHANJYGH-UHFFFAOYSA-L 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 229950011260 betanaphthol Drugs 0.000 claims description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethyl sulfoxide Natural products CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 3
- 125000003709 fluoroalkyl group Chemical group 0.000 claims description 3
- CTHCTLCNUREAJV-UHFFFAOYSA-N heptane-2,4,6-trione Chemical compound CC(=O)CC(=O)CC(C)=O CTHCTLCNUREAJV-UHFFFAOYSA-N 0.000 claims description 3
- 125000000623 heterocyclic group Chemical group 0.000 claims description 3
- 150000002431 hydrogen Chemical class 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 229910052744 lithium Inorganic materials 0.000 claims description 3
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 3
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 3
- KASKWOMRRXLJGW-UHFFFAOYSA-N naphthalene phosphane Chemical class P.C1=CC=CC2=CC=CC=C12 KASKWOMRRXLJGW-UHFFFAOYSA-N 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- JKDRQYIYVJVOPF-FDGPNNRMSA-L palladium(ii) acetylacetonate Chemical compound [Pd+2].C\C([O-])=C\C(C)=O.C\C([O-])=C\C(C)=O JKDRQYIYVJVOPF-FDGPNNRMSA-L 0.000 claims description 3
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
- 235000011181 potassium carbonates Nutrition 0.000 claims description 3
- 229910000160 potassium phosphate Inorganic materials 0.000 claims description 3
- 235000011009 potassium phosphates Nutrition 0.000 claims description 3
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
- 230000035484 reaction time Effects 0.000 claims description 3
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 claims description 3
- 230000003637 steroidlike Effects 0.000 claims description 3
- 125000003107 substituted aryl group Chemical group 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims description 2
- 239000004305 biphenyl Substances 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- 229910000078 germane Inorganic materials 0.000 claims description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 2
- GPAYUJZHTULNBE-UHFFFAOYSA-N diphenylphosphine Chemical compound C=1C=CC=CC=1PC1=CC=CC=C1 GPAYUJZHTULNBE-UHFFFAOYSA-N 0.000 claims 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N methyl cyanide Natural products CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 1
- WJEIYVAPNMUNIU-UHFFFAOYSA-N [Na].OC(O)=O Chemical compound [Na].OC(O)=O WJEIYVAPNMUNIU-UHFFFAOYSA-N 0.000 claims 1
- UJJKXKRXULKEAW-UHFFFAOYSA-N [P]C1CCCCC1 Chemical compound [P]C1CCCCC1 UJJKXKRXULKEAW-UHFFFAOYSA-N 0.000 claims 1
- CHXARDKIHSVFDK-UHFFFAOYSA-N hexylphosphane Chemical compound CCCCCCP CHXARDKIHSVFDK-UHFFFAOYSA-N 0.000 claims 1
- 229910052742 iron Inorganic materials 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 6
- 150000004756 silanes Chemical class 0.000 abstract description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 64
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 56
- 239000002585 base Substances 0.000 description 26
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 16
- 238000005160 1H NMR spectroscopy Methods 0.000 description 16
- 230000005311 nuclear magnetism Effects 0.000 description 16
- 239000003921 oil Substances 0.000 description 16
- 239000007832 Na2SO4 Substances 0.000 description 15
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 15
- 150000001875 compounds Chemical class 0.000 description 15
- 229910052938 sodium sulfate Inorganic materials 0.000 description 15
- 239000000243 solution Substances 0.000 description 14
- 239000004593 Epoxy Substances 0.000 description 13
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 13
- WLKSSWJSFRCZKL-UHFFFAOYSA-N trimethylgermanium Chemical compound C[Ge](C)C WLKSSWJSFRCZKL-UHFFFAOYSA-N 0.000 description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical group N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 0 CCCCC[C@@](CC)C1[C@@]([C@]2C(CCC)(**C[C@]3*CC3)CC2)[C@](C)C[C@]1C(C)=CCC(C)C(C)C Chemical compound CCCCC[C@@](CC)C1[C@@]([C@]2C(CCC)(**C[C@]3*CC3)CC2)[C@](C)C[C@]1C(C)=CCC(C)C(C)C 0.000 description 4
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 4
- RPGWZZNNEUHDAQ-UHFFFAOYSA-N phenylphosphine Chemical compound PC1=CC=CC=C1 RPGWZZNNEUHDAQ-UHFFFAOYSA-N 0.000 description 4
- RINOYHWVBUKAQE-UHFFFAOYSA-N 1-iodo-2-methylbenzene Chemical compound CC1=CC=CC=C1I RINOYHWVBUKAQE-UHFFFAOYSA-N 0.000 description 3
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 3
- 150000001335 aliphatic alkanes Chemical class 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 229910000077 silane Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 description 2
- DVQWNQBEUKXONL-UHFFFAOYSA-N 1-iodo-2-methoxybenzene Chemical compound COC1=CC=CC=C1I DVQWNQBEUKXONL-UHFFFAOYSA-N 0.000 description 2
- HHOXWPCTCQMHNN-UHFFFAOYSA-N C1(=CC=CC=C1)I.[F] Chemical compound C1(=CC=CC=C1)I.[F] HHOXWPCTCQMHNN-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical compound CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- YCOXTKKNXUZSKD-UHFFFAOYSA-N as-o-xylenol Natural products CC1=CC=C(O)C=C1C YCOXTKKNXUZSKD-UHFFFAOYSA-N 0.000 description 2
- OTTZHAVKAVGASB-UHFFFAOYSA-N hept-2-ene Chemical compound CCCCC=CC OTTZHAVKAVGASB-UHFFFAOYSA-N 0.000 description 2
- SNHMUERNLJLMHN-UHFFFAOYSA-N iodobenzene Chemical compound IC1=CC=CC=C1 SNHMUERNLJLMHN-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229940095102 methyl benzoate Drugs 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 150000003961 organosilicon compounds Chemical class 0.000 description 2
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 2
- 150000003376 silicon Chemical class 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000015424 sodium Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- WLPUWLXVBWGYMZ-UHFFFAOYSA-N tricyclohexylphosphine Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1 WLPUWLXVBWGYMZ-UHFFFAOYSA-N 0.000 description 2
- ROIMNSWDOJCBFR-UHFFFAOYSA-N 2-iodothiophene Chemical compound IC1=CC=CS1 ROIMNSWDOJCBFR-UHFFFAOYSA-N 0.000 description 1
- LNYCBUUFIWUHOZ-UHFFFAOYSA-N C(C)(C)OC1=C(C(=CC=C1)OC(C)C)C1=CC=CC=C1.[P] Chemical group C(C)(C)OC1=C(C(=CC=C1)OC(C)C)C1=CC=CC=C1.[P] LNYCBUUFIWUHOZ-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- METKIMKYRPQLGS-UHFFFAOYSA-N atenolol Chemical compound CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000006880 cross-coupling reaction Methods 0.000 description 1
- 229910021419 crystalline silicon Inorganic materials 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 150000002291 germanium compounds Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 125000000904 isoindolyl group Chemical class C=1(NC=C2C=CC=CC12)* 0.000 description 1
- UIUXUFNYAYAMOE-UHFFFAOYSA-N methylsilane Chemical compound [SiH3]C UIUXUFNYAYAMOE-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- JFNLZVQOOSMTJK-KNVOCYPGSA-N norbornene Chemical compound C1[C@@H]2CC[C@H]1C=C2 JFNLZVQOOSMTJK-KNVOCYPGSA-N 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- HJWDNWKQENUSKL-UHFFFAOYSA-N trimethyl(naphthalen-2-yloxy)silane Chemical compound C1=CC=CC2=CC(O[Si](C)(C)C)=CC=C21 HJWDNWKQENUSKL-UHFFFAOYSA-N 0.000 description 1
- PQDJYEQOELDLCP-UHFFFAOYSA-N trimethylsilane Chemical compound C[SiH](C)C PQDJYEQOELDLCP-UHFFFAOYSA-N 0.000 description 1
- 229940094989 trimethylsilane Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/0825—Preparations of compounds not comprising Si-Si or Si-cyano linkages
- C07F7/0827—Syntheses with formation of a Si-C bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/12—Organo silicon halides
- C07F7/121—Preparation or treatment not provided for in C07F7/14, C07F7/16 or C07F7/20
- C07F7/122—Preparation or treatment not provided for in C07F7/14, C07F7/16 or C07F7/20 by reactions involving the formation of Si-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/30—Germanium compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明公开了一种有机硅烷或有机锗烷衍生物的制备方法,包括如下步骤:(1)向经氮气吹扫的反应容器中依次加入碱、钯催化剂、配体、烯烃、卤代芳烃、六甲基二硅或六甲基二锗和有机溶剂,于40~120℃反应6~24h;(2)将步骤(1)所得的物料经乙酸乙酯稀释后,再经水洗,分离得有机相;(3)将步骤(2)所得的有机相经干燥、过滤、浓缩和柱层析色谱,得到所述有机硅烷或有机锗烷衍生物。本发明可以同时得到Csp2‑Si键和Csp3‑Si键的有机硅烷衍生物,并且有良好的区域选择性,能够合成其他方法不易得到的具有有机硅烷或有机锗烷衍生物。
Description
技术领域
本发明属于有机合成技术领域,具体涉及一种有机硅烷或有机锗烷衍生物的制备方法。
背景技术
有机硅或锗化合物是各种有机反应中的有价值的合成中间体,因为硅部分易于通过交叉偶联反应取代而转化为多种有机官能团。并且在材料科学、农业化学和药物化学等领域也发挥着重要作用。例如,在制药工业中,对已知药物的硅类似物以及全新的含硅分子,已成为一个活跃的研究领域,四氢异喹啉的硅类似物和三甲基硅-丙氨酸等有机硅在药物化学中的广泛应用。因此,开发高效和新颖的C-Si键形成方法一直是合成化学领域的研究热点。
发明内容
本发明的目的在于提供一种有机硅烷或有机锗烷衍生物的制备方法。
本发明的反应方程式如下:
本发明的技术方案如下:
一种有机硅烷或有机锗烷衍生物的制备方法,包括如下步骤:
(1)向经氮气吹扫的反应容器中依次加入碱、钯催化剂、配体、烯烃、卤代芳烃、六甲基二硅或六甲基二锗和有机溶剂,于40~120℃反应6~24h;
上述卤代芳烃的结构式为其中X为卤素,R为氢、烷基、烷氧基、酰基、氨基、三氟代烷氧基、芳基、取代芳基、羟基、羟甲基、卤素、杂环或甾体;
上述烯烃的结构式为其中Y为C、O或N;
上述钯催化剂为醋酸钯、三氟醋酸钯、二氯化钯、双三苯基膦基二氯化钯、双乙腈二氯化钯、乙酰丙酮钯、二乙酰丙酮钯、烯丙基氯化钯二聚物、四三苯基膦钯、[1,1′-双(二苯基膦)二茂铁]二氯化钯或三(二亚苄基丙酮)二钯;
上述配体为三苯基膦、三(2-呋喃基)膦、2-二环己基磷-2′,6′-二异丙氧基-1,1′-联苯、三萘基膦、2-二环己基磷-2,4,6-三异丙基联苯、2-双环己基膦-2',6'-二甲氧基联苯、三环己基膦、4,5-双二苯基膦-9,9-二甲基氧杂蒽、三(2-甲氧基苯基)膦、三(4-甲氧基苯基)膦、吡啶、联吡啶、2-羟基-3-三氟甲基吡啶,1,1′-联萘-2,2'-双二苯膦、1,1′-双(二苯基膦)二茂铁或1,1′-联-2-萘酚;
上述碱为氢氧化钠、氢氧化钾、叔丁醇锂、叔丁醇钠、叔丁醇钾、甲醇钠、乙醇钠、碳酸钠、碳酸钾、磷酸钾、磷酸二氢钾、碳酸铯或1,8-二氮杂二环十一碳-7-烯;
上述有机溶剂为二甲亚砜、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基-2-吡咯烷酮、1,2-二氯乙烷、甲苯、1,4-二氧六环、四氢呋喃或乙二醇二甲醚;
(2)将步骤(1)所得的物料经乙酸乙酯稀释后,再经水洗,分离得有机相;
(3)将步骤(2)所得的有机相经干燥、过滤、浓缩和柱层析色谱,得到所述有机硅烷或有机锗烷衍生物。
在本发明的一个优选实施方案中,所述R为卤素、三氟甲基或甲氧基。
进一步优选的,所述卤素为氟、碘、氯或溴。
在本发明的一个优选实施方案中,所述钯催化剂为醋酸钯,配体为三苯基膦,碱为碳酸铯,有机溶剂为N,N-二甲基甲酰胺。
在本发明的一个优选实施方案中,所述步骤(1)中的反应温度为60~100℃。
在本发明的一个优选实施方案中,所述步骤(1)中的反应时间为12h。
在本发明的一个优选实施方案中,所述卤代芳烃、六甲基二硅或六甲基二锗、烯烃、Pd催化剂、配体以及碱的摩尔比为1∶1.5∶2∶0.1∶0.2∶2,且每摩尔卤代芳烃对应的有机溶剂为1~2L。
本发明的有益效果是:
1、本发明可以同时得到Csp2-Si键和Csp3-Si键的有机硅烷衍生物,并且有良好的区域选择性,能够合成其他方法不易得到的具有有机硅烷或有机锗烷衍生物;
2、本发明的方法所用原料易得,收率高,反应条件温和,反应时间短,底物范围广,反应专一性强,后处理简便且绿色。
具体实施方式
以下通过具体实施方式对本发明的技术方案进行进一步的说明和描述。
实施例1
(2-(3-(三甲基甲硅烷基)-1,2,3,4-四氢-1,4-环氧萘-2-基)苯基)三甲基硅烷的制备
将碳酸铯0.2mmol,醋酸钯0.01mmol,三苯基膦0.02mmol,1,4-二氢-1,4-环氧基萘0.2mmol,碘苯0.1mmol,六甲基二硅0.15mmol,N,N-二甲基甲酰胺1ml加入到15ml的反应管中,氮气反复填充3次,置于100℃的油浴中,反应12h;冷却至室温,反应液用乙酸乙酯稀释,水洗三次,有机相用无水Na2SO4干燥,过滤,浓缩,柱层析纯化得到23.6mg目标产物,收率为61%。该化合物的核磁表征如下:1H NMR(500MHz,CDCl3)δ7.74(dd,J=7.8,0.6Hz,1H),7.42(dd,J=7.4,1.2Hz,1H),7.38(td,J=7.6,1.4Hz,1H),7.26(d,J=6.7Hz,1H),7.23(ddd,J=6.3,5.6,3.4Hz,2H),7.21-7.15(m,2H),5.40(s,1H),5.33(s,1H),3.24(d,J=9.6Hz,1H),1.34(d,J=9.6Hz,1H),0.19(s,9H),-0.22(s,9H).13C NMR(126MHz,CDCl3)δ149.9,147.9,145.6,138.8,133.9,129.7,127.9,126.6,126.2,125.8,118.6,117.9,86.8,80.5,48.6,38.4,0.61,-1.1.
实施例2
(3-甲氧基-2-(3-(三甲基甲硅烷基)-1,2,3,4-四氢-1,4-环氧萘-2-基)苯基)三甲基硅烷的制备
将碳酸铯0.2mmol,醋酸钯0.01mmol,三苯基膦0.02mmol,1,4-二氢-1,4-环氧基萘0.2mmol,邻甲氧基碘苯0.1mmol,六甲基二硅0.15mmol,N,N-二甲基甲酰胺1ml加入到15ml的反应管中,氮气反复填充3次,置于100℃的油浴中,反应12h;冷却至室温,反应液用乙酸乙酯稀释,水洗三次,有机相用无水Na2SO4干燥,过滤,浓缩,柱层析纯化得到35.3mg目标产物,收率为89%。该化合物的核磁表征如下:1H NMR(500MHz,CDCl3)δ7.24-7.17(m,3H),7.17-7.10(m,2H),7.04(dd,J=7.4,1.1Hz,1H),6.89(d,J=8.1Hz,1H),5.61(s,1H),5.38(s,1H),3.79(s,3H),3.31(d,J=10.3Hz,1H),1.28(s,1H),0.08(s,9H),-0.25(s,9H).13CNMR(126MHz,CDCl3)δ157.9,147.9,146.7,142.8,134.4,127.3,126.54,126.2,125.9,118.2,117.6,111.9,82.9,80.8,54.2,50.2,36.6,1.0,-1.4.
实施例3
(3-氯-2-(-3-(三甲基甲硅烷基)-1,2,3,4-四氢-1,4-环氧萘-2-基)苯基)三甲基硅烷的制备
将碳酸铯0.2mmol,醋酸钯0.01mmol,三苯基膦0.02mmol,1,4-二氢-1,4-环氧基萘0.2mmol,邻氯碘苯0.1mmol,六甲基二硅0.15mmol,N,N-二甲基甲酰胺1ml加入到15ml的反应管中,氮气反复填充3次,置于60℃的油浴中,反应12h;冷却至室温,反应液用乙酸乙酯稀释,水洗三次,有机相用无水Na2SO4干燥,过滤,浓缩,柱层析纯化得到35.1mg目标产物,收率为94%。该化合物的核磁表征如下:1H NMR(500MHz,CDCl3)δ7.39(dd,J=7.9,1.3Hz,1H),7.35(dd,J=7.4,1.4Hz,1H),7.25-7.21(m,2H),7.19-7.13(m,3H),5.93(s,1H),5.42(s,1H),3.50(d,J=10.5Hz,1H),1.36(d,J=10.5Hz,1H),0.08(s,9H),-0.19(s,9H).13C NMR(126MHz,CDCl3)δ146.9,146.8,145.1,143.7,133.3,133.2,133.2,127.4,126.6,126.2,118.3,117.8,81.6,80.6,52.1,37.7,1.1,-1.0.
实施例4
(4-甲基-2-(3-(三甲基甲硅烷基)-1,2,3,4-四氢-环氧萘-2-基)苯基)三甲基硅烷的制备
将碳酸铯0.2mmol,醋酸钯0.01mmol,三苯基膦0.02mmol,1,4-二氢-1,4-环氧基萘0.2mmol,间甲基碘苯0.1mmol,六甲基二硅0.15mmol,N,N-二甲基甲酰胺1ml加入到15ml的反应管中,氮气反复填充3次,置于100℃的油浴中,反应12h;冷却至室温,反应液用乙酸乙酯稀释,水洗三次,有机相用无水Na2SO4干燥,过滤,浓缩,柱层析纯化得到35.1mg目标产物,收率为94%。该化合物的核磁表征如下:1H NMR(500MHz,CDCl3)δ7.56(s,1H),7.31(d,J=7.6Hz,1H),7.25(t,J=5.8Hz,2H),7.21-7.14(m,2H),7.04(dd,J=7.6,0.9Hz,1H),5.40(s,1H),5.34(s,1H),3.21(d,J=9.6Hz,1H),2.35(s,3H),1.32(d,J=9.6Hz,1H),0.17(s,9H),-0.23(s,9H).13C NMR(126MHz,CDCl3)δ149.8,147.9,145.6,139.4,135.2,134.1,128.8,126.6,126.6,126.2,118.5,117.8,86.8,80.5,48.4,38.5,21.3,0.7,-1.2.
实施例5
(5-甲基-2-(3-(三甲基甲硅烷基)-1,2,3,4-四氢-1,4-环氧萘-2-基)苯基)三甲基硅烷的制备
将碳酸铯0.2mmol,醋酸钯0.01mmol,三苯基膦0.02mmol,1,4-二氢-1,4-环氧基萘0.2mmol,对甲基碘苯0.1mmol,六甲基二硅0.15mmol,N,N-二甲基甲酰胺1ml加入到15ml的反应管中,氮气反复填充3次,置于100℃的油浴中,反应12h;冷却至室温,反应液用乙酸乙酯稀释,水洗三次,有机相用无水Na2SO4干燥,过滤,浓缩,柱层析纯化得到21.9mg目标产物,收率为58%。该化合物的核磁表征如下:1H NMR(500MHz,CDCl3)δ7.63(d,J=7.9Hz,1H),7.24(dd,J=7.4,4.4Hz,2H),7.22-7.14(m,4H),5.39(s,1H),5.29(s,1H),3.21(d,J=9.6Hz,1H),2.34(s,3H),1.32(d,J=9.6Hz,1H),0.18(s,9H),-0.22(s,9H).13C NMR(126MHz,CDCl3)δ147.9,146.8,145.6,138.7,135.0,134.6,130.4,127.9,126.6,126.2,118.5,117.8,87.0,80.5,48.1,38.3,21.2,0.7,-1.0.
实施例6
(5-氟-2-((3-(三甲基甲硅烷基)-1,2,3,4-四氢-1,4-环氧萘-2-基)苯基)三甲基硅烷的制备
将碳酸铯0.2mmol,醋酸钯0.01mmol,三苯基膦0.02mmol,1,4-二氢-1,4-环氧基萘0.2mmol,对氟碘苯0.1mmol,六甲基二硅0.15mmol,N,N-二甲基甲酰胺1ml加入到15ml的反应管中,氮气反复填充3次,置于100℃的油浴中,反应12h;冷却至室温,反应液用乙酸乙酯稀释,水洗三次,有机相用无水Na2SO4干燥,过滤,浓缩,柱层析纯化得到23.8mg目标产物,收率为62%。该化合物的核磁表征如下:1H NMR(500MHz,CDCl3)δ7.74(dd,J=8.6,5.5Hz,1H),7.28(t,J=7.8Hz,2H),7.25-7.18(m,2H),7.14-7.06(m,2H),5.42(s,1H),5.30(s,1H),3.25(d,J=9.6Hz,1H),1.35(d,J=9.5Hz,1H),0.23(s,9H),-0.18(s,9H).13C NMR(126MHz,CDCl3)δ161.3(d,J=246.7Hz),147.9(s),145.4(d,J=3.1Hz),145.3,141.7(d,J=3.4Hz),129.6(d,J=6.8Hz),126.7,126.3,120.1(d,J=18.6Hz),118.6,117.9,116.2(d,J=20.7Hz),86.9,80.6,47.9,38.4,0.4,-1.1.
实施例7
N-(3-(三甲基硅烷基)-4-((3-(三甲基甲硅烷基)-1,2,3,4-四氢-1,4-环氧萘-2-基)苯基)乙酰胺的制备
将碳酸铯0.2mmol,醋酸钯0.01mmol,三苯基膦0.02mmol,1,4-二氢-1,4-环氧基萘0.2mmol,对乙酰氨基碘苯0.1mmol,六甲基二硅0.15mmol,N,N-二甲基甲酰胺1ml加入到15ml的反应管中,氮气反复填充3次,置于100℃的油浴中,反应12h;冷却至室温,反应液用乙酸乙酯稀释,水洗三次,有机相用无水Na2SO4干燥,过滤,浓缩,柱层析纯化得到21.8mg目标产物,收率为61%。该化合物的核磁表征如下:1H NMR(500MHz,CDCl3)δ7.70(d,J=8.5Hz,1H),7.63(dd,J=8.5,2.3Hz,1H),7.46(d,J=2.3Hz,1H),7.35(s,1H),7.26-7.22(m,2H),7.21-7.14(m,2H),5.39(s,1H),5.27(s,1H),3.21(d,J=9.6Hz,1H),2.17(s,3H),1.32(d,J=9.6Hz,1H),0.19(s,9H),-0.21(s,9H).13C NMR(126MHz,CDCl3)δ168.2,147.9,145.7,145.4,139.8,135.8,128.5,126.6,126.2,124.9,121.1,118.6,117.8,86.8,80.5,38.4,24.6,0.5,-1.01.
实施例8
3-甲基-5-(三甲基甲硅烷基)-4-(3-(三甲基甲硅烷基)-1,2,3,4-四氢-1,4-环氧基萘-2-基)苯甲酸甲酯的制备
将碳酸铯0.2mmol,醋酸钯0.01mmol,三苯基膦0.02mmol,1,4-二氢-1,4-环氧基萘0.2mmol,4-碘-3-甲基苯甲酸甲酯0.1mmol,六甲基二硅0.15mmol,N,N-二甲基甲酰胺1ml加入到15ml的反应管中,氮气反复填充3次,置于100℃的油浴中,反应12h;冷却至室温,反应液用乙酸乙酯稀释,水洗三次,有机相用无水Na2SO4干燥,过滤,浓缩,柱层析纯化得到36.3mg目标产物,收率为83%。该化合物的核磁表征如下:1H NMR(500MHz,CDCl3)δ7.95(d,J=1.9Hz,1H),7.85(d,J=1.8Hz,1H),7.26-7.22(m,2H),7.22-7.15(m,2H),5.65(s,1H),5.42(s,1H),3.91(s,3H),3.58(d,J=10.6Hz,1H),2.72(s,3H),1.40(d,J=10.6Hz,1H),0.10(s,9H),-0.27(s,9H).13C NMR(126MHz,CDCl3)δ167.4,150.7,146.8,146.1,143.1,136.7,135.1,133.5,127.5,126.8,126.4,118.2,118.1,81.6,80.5,52.4,52.0,38.2,22.0,1.1,-1.0.
实施例9
2-甲基-4-(三甲基甲硅烷基)-3-(3-(三甲基甲硅烷基)-1,2,3,4-四氢-1,4-环氧萘-2-基)苯甲酸甲酯的制备
将碳酸铯0.2mmol,醋酸钯0.01mmol,三苯基膦0.02mmol,1,4-二氢-1,4-环氧基萘0.2mmol,3-碘-2-甲基苯甲酸甲酯0.1mmol,六甲基二硅0.15mmol,N,N-二甲基甲酰胺1ml加入到15ml的反应管中,氮气反复填充3次,置于100℃的油浴中,反应12h;冷却至室温,反应液用乙酸乙酯稀释,水洗三次,有机相用无水Na2SO4干燥,过滤,浓缩,柱层析纯化得到34.8mg目标产物,收率为79%。该化合物的核磁表征如下:1H NMR(500MHz,CDCl3)δ7.47(d,J=7.7Hz,1H),7.34(d,J=7.7Hz,1H),7.24(t,J=6.6Hz,2H),7.21-7.14(m,2H),5.62(s,1H),5.44(s,1H),3.90(s,3H),3.58(d,J=10.6Hz,1H),2.77(s,3H),1.40(d,J=10.6Hz,1H),0.06(s,9H),-0.24(s,9H).13C NMR(126MHz,CDCl3)δ169.9,146.5,146.5,146.5,146.4,135.9,135.2,132.2,126.7,126.7,126.2,118.3,118.0,82.1,80.7,53.0,52.1,37.6,18.4,1.0,-1.0.
实施例10
2-苄基-5-(三甲基硅烷基)-6-(2-(三甲基甲硅烷氧基)萘-1-基)六氢-1H-4,7-亚甲基异吲哚-1,3(2H)-二酮的制备
将碳酸铯0.2mmol,醋酸钯0.01mmol,三苯基膦0.02mmol,内型-N-苄基二环[2.2.1]庚-2-烯-5,6-二甲酰亚胺0.2mmol,1-碘萘0.1mmol,六甲基二硅0.15mmol,N,N-二甲基甲酰胺1ml加入到15ml的反应管中,氮气反复填充3次,置于60℃的油浴中,反应12h;冷却至室温,反应液用乙酸乙酯稀释,水洗三次,有机相用无水Na2SO4干燥,过滤,浓缩,柱层析纯化得到46.7mg目标产物,收率为89%。该化合物的核磁表征如下:1H NMR(500MHz,CDCl3)δ8.55(d,J=8.5Hz,1H),7.83(dd,J=7.8,1.8Hz,1H),7.72(d,J=8.3Hz,1H),7.62(d,J=8.3Hz,1H),7.50-7.41(m,4H),7.38-7.30(m,3H),4.75(s,2H),3.98(s,1H),3.75(d,J=10.8Hz,1H),3.40-3.31(m,2H),2.82(dd,J=24.3,6.2Hz,2H),2.22-2.19(m,1H),2.02(d,J=10.3Hz,1H),1.73(dd,J=10.9,2.1Hz,1H),0.45-0.41(m,9H),-0.69--0.74(m,9H).13CNMR(126MHz,CDCl3)δ177.5,176.9,145.3,139.7,135.9,135.6,131.7,131.6,129.1,129.1,128.6,128.0,127.0,125.5,125.4,124.9,51.5,50.9,50.2,45.8,45.1,42.7,41.3,38.8,2.0,-1.2.
实施例11
(1-(3-(三甲基锗)双环[2.2.1]庚-2-基)萘-2-基)三甲基锗的制备
将碳酸铯0.2mmol,醋酸钯0.01mmol,三苯基膦0.02mmol,降冰片烯0.2mmol,1-碘萘0.1mmol,六甲基二锗0.15mmol,N,N-二甲基甲酰胺1ml加入到15ml的反应管中,氮气反复填充3次,置于60℃的油浴中,反应12h;冷却至室温,反应液用乙酸乙酯稀释,水洗三次,有机相用无水Na2SO4干燥,过滤,浓缩,柱层析纯化得到41.4mg目标产物,收率为91%。该化合物的核磁表征如下:1H NMR(500MHz,CDCl3)δ8.58(dd,J=6.3,3.5Hz,1H),7.79(dd,J=6.2,3.4Hz,1H),7.66(d,J=8.2Hz,1H),7.50(d,J=8.2Hz,1H),7.46-7.36(m,2H),3.73(d,J=10.6Hz,1H),3.07(d,J=1.6Hz,1H),2.42(d,J=4.3Hz,1H),2.29(d,J=9.8Hz,1H),1.91(tdd,J=12.1,4.7,3.0Hz,1H),1.74-1.62(m,2H),1.59-1.54(m,2H),1.45(dddd,J=14.5,8.5,6.0,2.2Hz,1H),0.53(s,9H),-0.60(s,9H).13CNMR(126MHz,CDCl3)δ146.7,141.7,135.2,132.0,130.7,128.7,126.4,126.2,125.2,124.5,54.7,47.1,42.5,40.1,39.9,34.0,31.8,1.7,-1.5.
实施例12
(3-甲氧基-2-(3-(三甲基锗)-1,2,3,4-四氢-1,4-环氧萘-2-基)苯基)三甲基锗的制备
将碳酸铯0.2mmol,醋酸钯0.01mmol,三苯基膦0.02mmol,1,4-二氢-1,4-环氧基萘0.2mmol,邻甲氧基碘苯0.1mmol,六甲基二锗0.15mmol,N,N-二甲基甲酰胺1ml加入到15ml的反应管中,氮气反复填充3次,置于100℃的油浴中,反应12h;冷却至室温,反应液用乙酸乙酯稀释,水洗三次,有机相用无水Na2SO4干燥,过滤,浓缩,柱层析纯化得到40.2mg目标产物,收率为83%。该化合物的核磁表征如下:1H NMR(500MHz,CDCl3)δ7.23-7.19(m,2H),7.18(d,J=7.3Hz,1H),7.16-7.10(m,2H),6.98(dd,J=7.4,1.1Hz,1H),6.86(d,J=8.1Hz,1H),5.64(s,1H),5.35(s,1H),3.79(s,3H),3.23(d,J=10.0Hz,1H),1.44(d,J=10.0Hz,1H),0.17(s,9H),-0.13(s,9H).13C NMR(126MHz,CDCl3)δ158.0,148.0,146.4,145.4,133.7,127.3,126.2,126.0,125.6,118.4,117.6,111.4,82.8,81.4,54.3,50.6,37.9,0.5,-1.8.
实施例13
(3-甲基-2-(3-(三甲基锗烷基)-1,2,3,4-四氢-1,4-环氧萘-2-基)苯基)三甲基锗烷的制备
将碳酸铯0.2mmol,醋酸钯0.01mmol,三苯基膦0.02mmol,1,4-二氢-1,4-环氧基萘0.2mmol,邻甲基碘苯0.1mmol,六甲基二锗0.15mmol,N,N-二甲基甲酰胺1ml加入到15ml的反应管中,氮气反复填充3次,置于100℃的油浴中,反应12h;冷却至室温,反应液用乙酸乙酯稀释,水洗三次,有机相用无水Na2SO4干燥,过滤,浓缩,柱层析纯化得到28.6mg目标产物,收率为61%。该化合物的核磁表征如下:1H NMR(500MHz,CDCl3)δ7.23(ddd,J=5.2,3.7,1.5Hz,3H),7.20-7.14(m,3H),7.12(t,J=7.3Hz,1H),5.66(s,1H),5.38(s,1H),3.47(d,J=10.3Hz,1H),2.65(s,3H),1.55(d,J=10.3Hz,1H),0.16(s,9H),-0.14(s,9H).13C NMR(126MHz,CDCl3)δ146.7,146.3,144.9,144.1,136.5,133.6,131.7,126.6,126.3,126.2,118.4,118.0,81.9,81.2,52.4,39.0,21.8,0.8,-1.5.
实施例14
(2-(3-(三甲基锗烷基)-1,2,3,4-四氢-1,4-环氧萘-2-基)噻吩-3-基)三甲基锗烷的制备
将碳酸铯0.2mmol,醋酸钯0.01mmol,三苯基膦0.02mmol,1,4-二氢-1,4-环氧基萘0.2mmol,2-碘噻吩0.1mmol,六甲基二锗0.15mmol,N,N-二甲基甲酰胺1ml加入到15ml的反应管中,氮气反复填充3次,置于100℃的油浴中,反应12h;冷却至室温,反应液用乙酸乙酯稀释,水洗三次,有机相用无水Na2SO4干燥,过滤,浓缩,柱层析纯化得到24.3mg目标产物,收率为53%。该化合物的核磁表征如下:1H NMR(500MHz,CDCl3)δ7.21-7.15(m,3H),7.15-7.08(m,2H),6.83(d,J=5.0Hz,1H),5.27(s,1H),5.24(s,1H),3.42(d,J=9.2Hz,1H),1.41(d,J=9.2Hz,1H),0.25(s,9H),-0.07(s,9H).13C NMR(126MHz,CDCl3)δ152.3,147.4,144.6,137.7,130.5,126.9,126.4,124.0,119.0,117.8,86.9,81.7,45.6,39.2,-0.2,-1.6.
实例15
(3-氟-2-(3-(三甲基锗烷基)-1,2,3,4-四氢-1,4-环氧萘-2-基)苯基)三甲基锗烷的制备
将碳酸铯0.2mmol,醋酸钯0.01mmol,三苯基膦0.02mmol,1,4-二氢-1,4-环氧基萘0.2mmol,邻氟碘苯0.1mmol,六甲基二锗0.15mmol,N,N-二甲基甲酰胺1ml加入到15ml的反应管中,氮气反复填充3次,置于100℃的油浴中,反应12h;冷却至室温,反应液用乙酸乙酯稀释,水洗三次,有机相用无水Na2SO4干燥,过滤,浓缩,柱层析纯化得到32.8mg目标产物,收率为69%。该化合物的核磁表征如下:1H NMR(500MHz,CDCl3)δ7.25-7.22(m,2H),7.22-7.19(m,1H),7.19-7.13(m,3H),7.05(ddd,J=11.6,8.0,1.3Hz,1H),5.59(d,J=2.4Hz,1H),5.39(s,1H),3.21(d,J=9.9Hz,1H),1.49(d,J=9.9Hz,1H),0.23(s,9H),-0.09(d,J=0.8Hz,9H).13C NMR(126MHz,CDCl3)δ161.0(d,J=252.9Hz),146.7(d,J=81.7Hz),146.4,133.3(d,J=11.9Hz),129.2(d,J=3.2Hz),127.9(d,J=7.4Hz),126.6,126.2,118.4,117.9,117.5,117.3,83.3(d,J=2.7Hz),81.6,49.1(d,J=3.2Hz),38.6,0.3,-1.9.(d,J=2.4Hz).
实施例16
2-烯丙基-5-(三甲基锗烷基)-6-(2-(三甲基锗烷基)萘-1-基)六氢-1H-4,7-亚甲基异吲哚-1,3(2H)-二酮的制备
将碳酸铯0.2mmol,醋酸钯0.01mmol,三苯基膦0.02mmol,2-烯丙基-3α,4,7,7a四氢-1H-4,7-亚甲基异吲哚-1,3-(2H)-二酮0.2mmol,1-碘萘0.1mmol,六甲基二锗0.15mmol,N,N-二甲基甲酰胺1ml加入到15ml的反应管中,氮气反复填充3次,置于100℃的油浴中,反应12h;冷却至室温,反应液用乙酸乙酯稀释,水洗三次,有机相用无水Na2SO4干燥,过滤,浓缩,柱层析纯化得到32.8mg目标产物,收率为69%。该化合物的核磁表征如下:1H NMR(500MHz,CDCl3)δ8.53-8.48(m,1H),7.82-7.77(m,1H),7.66(d,J=8.2Hz,1H),7.52(d,J=8.2Hz,1H),7.44-7.39(m,2H),5.82(ddt,J=16.2,10.2,6.0Hz,1H),5.27(dd,J=17.1,1.2Hz,1H),5.21(dd,J=10.2,1.1Hz,1H),4.18(d,J=6.0Hz,2H),3.97(s,1H),3.58(d,J=10.6Hz,1H),3.42-3.36(m,2H),2.81(d,J=1.8Hz,1H),2.73(d,J=10.4Hz,1H),2.02(d,J=10.1Hz,1H),1.88(dd,J=10.6,2.3Hz,1H),0.44(s,9H),-0.62(s,9H).13C NMR(126MHz,CDCl3)δ177.3,176.8,144.0,142.4,135.4,131.6,131.0,130.7,129.3,127.1,125.3,125.2,125.0,118.7,51.5,50.8,50.7,45.6,44.9,41.9,41.3,40.2,1.5,-1.5.
本领域普通技术人员可知,本发明的技术方案在下述范围内变化时,仍然能够得到与上述实施例相同或相近的技术效果:
一种有机硅烷或有机锗烷衍生物的制备方法,包括如下步骤:
(1)向经氮气吹扫的反应容器中依次加入碱、钯催化剂、配体、烯烃、卤代芳烃、六甲基二硅或六甲基二锗和有机溶剂,于40~120℃反应6~24h;
上述卤代芳烃的结构式为其中X为卤素,R为氢、烷基、烷氧基、酰基、氨基、三氟代烷氧基、芳基、取代芳基、羟基、羟甲基、卤素、杂环或甾体;
上述烯烃的结构式为其中Y为C、O或N;
上述钯催化剂为醋酸钯、三氟醋酸钯、二氯化钯、双三苯基膦基二氯化钯、双乙腈二氯化钯、乙酰丙酮钯、二乙酰丙酮钯、烯丙基氯化钯二聚物、四三苯基膦钯、[1,1′-双(二苯基膦)二茂铁]二氯化钯或三(二亚苄基丙酮)二钯;
上述配体为三苯基膦、三(2-呋喃基)膦、2-二环己基磷-2',6'-二异丙氧基-1,1′-联苯、三萘基膦、2-二环己基磷-2,4,6-三异丙基联苯、2-双环己基膦-2′,6′-二甲氧基联苯、三环己基膦、4,5-双二苯基膦-9,9-二甲基氧杂蒽、三(2-甲氧基苯基)膦、三(4-甲氧基苯基)膦、吡啶、联吡啶、2-羟基-3-三氟甲基吡啶,1,1′-联萘-2,2'-双二苯膦、1,1'-双(二苯基膦)二茂铁或1,1′-联-2-萘酚;
上述碱为氢氧化钠、氢氧化钾、叔丁醇锂、叔丁醇钠、叔丁醇钾、甲醇钠、乙醇钠、碳酸钠、碳酸钾、磷酸钾、磷酸二氢钾、碳酸铯或1,8-二氮杂二环十一碳-7-烯;
上述有机溶剂为二甲亚砜、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基-2-吡咯烷酮、1,2-二氯乙烷、甲苯、1,4-二氧六环、四氢呋喃或乙二醇二甲醚;
(2)将步骤(1)所得的物料经乙酸乙酯稀释后,再经水洗,分离得有机相;
(3)将步骤(2)所得的有机相经干燥、过滤、浓缩和柱层析色谱,得到所述有机硅烷或有机锗烷衍生物。
以上所述,仅为本发明的较佳实施例而已,故不能依此限定本发明实施的范围,即依本发明专利范围及说明书内容所作的等效变化与修饰,皆应仍属本发明涵盖的范围内。
Claims (7)
1.一种有机硅烷或有机锗烷衍生物的制备方法,其特征在于:包括如下步骤:
(1)向经氮气吹扫的反应容器中依次加入碱、钯催化剂、配体、烯烃、卤代芳烃、六甲基二硅或六甲基二锗和有机溶剂,于40~120℃反应6~24h;
上述卤代芳烃的结构式为其中X为卤素,R为氢、烷基、烷氧基、酰基、氨基、三氟代烷氧基、芳基、取代芳基、羟基、羟甲基、卤素、杂环或甾体;
上述烯烃的结构式为其中Y为C、O或N;
上述钯催化剂为醋酸钯、三氟醋酸钯、二氯化钯、双三苯基膦基二氯化钯、双乙腈二氯化钯、乙酰丙酮钯、二乙酰丙酮钯、烯丙基氯化钯二聚物、四三苯基膦钯、[1,1'-双(二苯基膦)二茂铁]二氯化钯或三(二亚苄基丙酮)二钯;
上述配体为三苯基膦、三(2-呋喃基)膦、2-2环己基磷-2',6'-二异丙氧基-1,1′-联苯、三萘基膦、2-二环己基磷-2,4,6-三异丙基联苯、2-双环己基膦-2',6'-二甲氧基联苯、三环己基膦、4,5-双二苯基膦-9,9-二甲基氧杂蒽、三(2-甲氧基苯基)膦、三(4-甲氧基苯基)膦、吡啶、联吡啶、2-羟基-3-三氟甲基吡啶,1,1′-联萘-2,2'-双二苯膦、1,1′-双(二苯基膦)二茂铁或1,1′-联-2-萘酚;
上述碱为氢氧化钠、氢氧化钾、叔丁醇锂、叔丁醇钠、叔丁醇钾、甲醇钠、乙醇钠、碳酸钠、碳酸钾、磷酸钾、磷酸二氢钾、碳酸铯或1,8-二氮杂二环十一碳-7-烯;
上述有机溶剂为二甲亚砜、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基-2-吡咯烷酮、1,2-二氯乙烷、甲苯、1,4-二氧六环、四氢呋喃或乙二醇二甲醚;
(2)将步骤(1)所得的物料经乙酸乙酯稀释后,再经水洗,分离得有机相;
(3)将步骤(2)所得的有机相经干燥、过滤、浓缩和柱层析色谱,得到所述有机硅烷或有机锗烷衍生物。
2.如权利要求1所述的制备方法,其特征在于:所述R为卤素、三氟甲基或甲氧基。
3.如权利要求1或2所述的制备方法,其特征在于:所述卤素为氟、碘、氯或溴。
4.如权利要求1所述的制备方法,其特征在于:所述钯催化剂为醋酸钯,配体为三苯基膦,碱为碳酸铯,有机溶剂为N,N-二甲基甲酰胺。
5.如权利要求1所述的制备方法,其特征在于:所述步骤(1)中的反应温度为60~100℃。
6.如权利要求1所述的制备方法,其特征在于:所述步骤(1)中的反应时间为12h。
7.如权利要求1所述的制备方法,其特征在于:所述卤代芳烃、六甲基二硅或六甲基二锗、烯烃、钯催化剂、配体以及碱的摩尔比为1∶1.5∶2∶0.1∶0.2∶2,且每摩尔卤代芳烃对应的有机溶剂为1~2L。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810417009.0A CN108586519A (zh) | 2018-05-03 | 2018-05-03 | 一种有机硅烷或有机锗烷衍生物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810417009.0A CN108586519A (zh) | 2018-05-03 | 2018-05-03 | 一种有机硅烷或有机锗烷衍生物的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108586519A true CN108586519A (zh) | 2018-09-28 |
Family
ID=63619722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810417009.0A Pending CN108586519A (zh) | 2018-05-03 | 2018-05-03 | 一种有机硅烷或有机锗烷衍生物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108586519A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109021003A (zh) * | 2018-07-06 | 2018-12-18 | 华侨大学 | 一种乙烯基硅\锗\锡烷衍生物的制备方法 |
CN109879713A (zh) * | 2019-02-22 | 2019-06-14 | 华侨大学 | 一种反式四取代烯烃衍生物的制备方法 |
CN109879899A (zh) * | 2019-02-22 | 2019-06-14 | 华侨大学 | 一种反式三取代烯烃衍生物的制备方法 |
-
2018
- 2018-05-03 CN CN201810417009.0A patent/CN108586519A/zh active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109021003A (zh) * | 2018-07-06 | 2018-12-18 | 华侨大学 | 一种乙烯基硅\锗\锡烷衍生物的制备方法 |
CN109021003B (zh) * | 2018-07-06 | 2021-06-01 | 华侨大学 | 一种乙烯基硅\锗\锡烷衍生物的制备方法 |
CN109879713A (zh) * | 2019-02-22 | 2019-06-14 | 华侨大学 | 一种反式四取代烯烃衍生物的制备方法 |
CN109879899A (zh) * | 2019-02-22 | 2019-06-14 | 华侨大学 | 一种反式三取代烯烃衍生物的制备方法 |
CN109879899B (zh) * | 2019-02-22 | 2021-08-31 | 华侨大学 | 一种反式三取代烯烃衍生物的制备方法 |
CN109879713B (zh) * | 2019-02-22 | 2021-11-02 | 华侨大学 | 一种反式四取代烯烃衍生物的制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kirsch et al. | Synthesis of five-and six-membered heterocycles through palladium-catalyzed reactions | |
CN108047261A (zh) | 一种克立硼罗的制备方法 | |
CN108586519A (zh) | 一种有机硅烷或有机锗烷衍生物的制备方法 | |
CN104926811B (zh) | 3-氰基咪唑并[1,2-a]吡啶化合物的合成方法及其应用 | |
CN107973779B (zh) | 一种n-(2-吡啶/嘧啶基)吲哚衍生物的制备方法 | |
CN110204486B (zh) | 一种喹啉衍生物的合成方法 | |
CN109021003B (zh) | 一种乙烯基硅\锗\锡烷衍生物的制备方法 | |
CN114105978A (zh) | 一种氧化吲哚类化合物及其制备方法和应用 | |
CN110128393B (zh) | 一种取代异香豆素衍生物的制备方法 | |
CN112209876B (zh) | 一种3-三氟甲基异喹啉酮衍生物的制备方法 | |
CN108864160A (zh) | 含硼小分子的制备方法 | |
CN108610304B (zh) | 一种二芳并磺内酰胺类化合物的合成方法 | |
CN103739536A (zh) | 一种二芳基双硒醚化合物的合成方法 | |
CN105017299A (zh) | 一种1,4-二烯基硼化合物的制备方法 | |
CN110938058A (zh) | 一种噁唑烷酮类抗生素中间体的制备方法 | |
CN108864164B (zh) | 一种一级胺导向的2-炔基吲哚类化合物的合成方法 | |
CN110156710A (zh) | 一种多取代噁唑类化合物的制备方法 | |
Bergauer et al. | Diethoxymethyl protected pyrroles: synthesis and regioselective transformations | |
CN107382858B (zh) | 系列1,2,3,4-四氢异喹啉-4-酮化合物及其合成方法与应用 | |
CN112174880B (zh) | 一种1,3,4,6-四取代吡啶酮衍生物的制备方法 | |
CN109824530B (zh) | 一种由芳香羧酸合成邻氨基芳香酮的方法 | |
CN110407830B (zh) | 一种合成n-芳基吩噻嗪类化合物的方法 | |
CN109988113B (zh) | 一种[60]富勒烯四氢喹啉衍生物的合成方法 | |
CN108373482B (zh) | 一种3-炔基异香豆素类化合物的制备方法 | |
CN113214162A (zh) | 一种苯并咪唑衍生物的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180928 |